Trial Profile
Phase II trial of weekly Nab-Paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2014
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Dec 2014 New trial record